Senior Research Scientist
TxCORE Executive Director
Michael Johnsrud, Ph.D., R.Ph., is Executive Director of the Texas Center for Health Outcomes Research and Education (TxCORE) and a Senior Research Scientist in Health Outcomes at The University of Texas at Austin College of Pharmacy, where he designs and conducts research to analyze how prescription drugs, medical devices, and various clinical interventions and services impact resource utilization, patient health outcomes, and quality of life. Mike has particular expertise in prescription drug pricing, as well as coverage and reimbursement policy in Medicaid, Medicare, and private-sector health plans. He also studies the economics of the marketplace for community pharmacy and prescription drug benefit programs.
Prior to his role at TxCORE, Mike was a Senior Vice President at Avalere Health in Washington, DC, where he led the Health Economics and Advanced Analytics Practice. While at Avalere Health, he provided strategic and scientific guidance to the firm’s clients to support the design and generation of clinical and economic evidence to inform stakeholders in the marketplace in determining the value of various medications and interventions.
Prior to joining Avalere Health, Mike was Associate Director of The Center for Pharmacoeconomic Studies at The University of Texas at Austin College of Pharmacy. He has published numerous articles over the course of his career related to pharmaceutical economics, medication adherence, and the value and cost-effectiveness of prescription drugs and clinical interventions across a variety of different therapeutic areas.
Mike received his B.S. in Pharmacy from the University of Iowa and a M.S. and Ph.D. in Pharmacy Administration from the University of Texas at Austin. He is a registered pharmacist in Iowa and Texas.
Education
Ph.D., The University of Texas at Austin
M.S., The University of Texas at Austin
B.S. Pharmacy, The University of Iowa
Selected Recent Publications
CORE Research Area: Patient-Centered Outcomes Research
Richards K, Mantri S, Brown CM, Johnsrud M, Arcona S. A qualitative study on perspectives of Parkinson’s disease medications: Insights from patient focus groups. Patient Preference and Adherence 2024; 18: 1919-28.
Heidari E, Brown C, Johnsrud M, Mastrangelo V, Spears A, Parikh M, Campbell PJ. Procurement and use of social determinants of health data among key health care stakeholders. Journal of Managed Care and Specialty Pharmacy 2022; 28 (5): 538-543.
Moczygemba LR, Brown C, Johnsrud M. "It's time to represent": Shifting the paradigm to improve the quality of inputs into value assessment frameworks. Journal of Managed Care and Specialty Pharmacy 2021; 27 (9-a Suppl): S19-S23.
CORE Research Area: Healthcare Systems Research
Briggs O, Brown CM, Indurlal P, Garey JS, Johnsrud M. Provider perceptions of barriers to biosimilar utilization in community oncology practices. Journal of the American Pharmacists Association 2024; 64 (4): 102082
Drozd E, Miller L, Johnsrud M. Impact of pharmacist immunization authority on seasonal influenza immunization rates across states. Clinical Therapeutics 2017; 39 (8): 1563-80.
Schmitt S, McQuillen DP, Nahass R, Martinelli L, Rubin M, Schwebke K, Petrak R, Ritter JT, Chansolme D, Slama T, Drozd EM, Braithwaite SF, Johnsrud M, Hammelman E. Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clinical Infectious Diseases 2014; 58 (1): 22-8.
CORE Research Area: Health Economics and Outcomes Research
Richards K, Johnsrud M, Zacker C, Sasané R. Association between persistence with oral atypical antipsychotic medications and hospital and emergency department utilization in Medicaid patients with schizophrenia. Patient Preference and Adherence. 2024; 18: 177-85.
Richards K, Johnsrud M, Zacker C, Sasané R. Detailing healthcare claims data evidence of extrapyramidal symptoms in Medicaid patients with schizophrenia after second-generation antipsychotic medication initiation. Community Mental Health Journal. 2024.
Richards K, Johnsrud M, Zacker C, Sasané R. One-year medication treatment patterns, healthcare resource utilization, and expenditures for Medicaid patients with schizophrenia starting oral atypical antipsychotic medication. Administration and Policy in Mental Health and Mental Health Services Research. 2024; 2: 207-16.
Johnsrud M, Richards K, Arcona S, Sasané R, Leoni M. An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population. Clinical Parkinsonism and Related Disorders. 2021; 5: 1-6.